Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-021104·Tvardi Therapeutics, Inc.
Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755208
Event date: 2025-07-07
- Filing-level shares
- 315,658.00
- Percent of class
- 3.4%
- Samuel D. Tweardy
Shares: 315,658.00 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021104
- Form type
- SCHEDULE 13G/A
- Filer
- Tvardi Therapeutics, Inc.
- CIK
- CIK 1346830
- Filed
- Aug 05, 2025
- Reporting period
- Jul 07, 2025
- Description
- Schedule 13G beneficial ownership